Banner
Structure

Tetrakis(hydroxymethyl)phosphonium Chloride (ca. 80% in Water)

CAS
124-64-1
Catalog Number
ACM124641-2
Category
Main Products
Molecular Weight
190.56g/mol
Molecular Formula
C4H12ClO4P;

If you have any other questions or need other size, please get a quote.

  • Product Description
  • Case Study
  • Custom Reviews
  • Custom Q&A
  • Synthetic Use
  • Related Resources

Specification

Synonyms
KSC492Q8N; tetrakis(hydroxymethyl)phosphanium chloride; Pyroset TKC; SC-80017; UNII-58WB2XCF8I; Tetrakis(hydroxymethyl)phosphonium chloride, ca. 80% solution in water; MFCD00031687; EC 204-707-7; NSC30698; Phosphonium, tetrakis(hydroxymethyl)-, chloride;
IUPAC Name
tetrakis(hydroxymethyl)phosphanium;chloride;
Canonical SMILES
C(O)[P+](CO)(CO)CO.[Cl-];
InChI
InChI=1S/C4H12O4P.ClH/c5-1-9(2-6,3-7)4-8;/h5-8H,1-4H2;1H/q+1;/p-1;
InChI Key
AKXUUJCMWZFYMV-UHFFFAOYSA-M;
Melting Point
154 deg C;
Density
1.322 at 64 ° F (NTP, 1992);1.341;
Solubility
greater than or equal to 100 mg/mL at 68° F (NTP, 1992);In water, 40,000 mg/l, temp not specified.;
Color/Form
Crystalline;
Complexity
55.5
Corrosivity
Corrosive;
Covalently-Bonded Unit Count
2
Decomposition
When heated to decomposition it emits very toxic fumes of /phosphorous oxides & hydrogen chloride/.;TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM CHLORIDE DEGRADES THERMALLY & UNDER CERTAIN CHEMICAL CONDITIONS TO YIELD HYDROCHLORIC ACID & FORMALDEHYDE. IN SOLN, THE LATTER 2 CMPDS ARE IN EQUILIBRIUM WITH THE KNOWN POTENT CARCINOGEN BIS(CHLOROMETHYL)ETHER. PubMed Abstract;
EC Number
204-707-7
Exact Mass
190.016g/mol
H-Bond Acceptor
5
H-Bond Donor
4
Heavy Atom Count
10
Monoisotopic Mass
190.016g/mol
NSC Number
30698
Physical Description
TETRAKIS(HYDROXYMETHYL)PHOSPHONIUM CHLORIDE is a clear slightly viscous,colorless to yellow liquid (20% H₂O solution). (NTP, 1992);Liquid;
Rotatable Bond Count
4
RTECS Number
TA2450000
Topological Polar Surface Area
80.9A^2
UNII
58WB2XCF8I
UN Number
2810
Vapor Pressure
1 mm Hg at 77 ° F ; 6.0 mm Hg at 84° F; 110.0 mm Hg at 124° F (NTP, 1992);

Tetrakis(Hydroxymethyl)Phosphonium Chloride for Cell Encapsulation in Protein-Based Hydrogels

Cindy Chung, et al. Biomacromolecules, 2012, 13(12), 3912-3916.

Tetrakis(hydroxymethyl)phosphonium chloride (THPC) can be used as an inexpensive, amine-reactive, aqueous crosslinker for 3D cell encapsulation in protein-based hydrogels. This work demonstrates the use of THPC in modulating hydrogel properties and shows cytocompatibility for cell growth and phenotypic retention in elastin-like protein (ELP) hydrogel systems.
THPC-amine reaction mechanism and characterization
· The Mannich reaction begins with the formation of formaldehyde (HCOH), which then combines with an amine to form an immonium ion. This immonium ion then reacts with the THPC derivative to substitute the hydroxymethyl arm, leading to the coupling of the amine. Further reactions with other amines can proceed in a comparable fashion with any remaining unreacted hydroxymethyl arms.
· THPC-amine reaction was characterized by demonstrating the ability of THPC to react with primary and secondary amines of various amino acids. The Mannich-type reaction was analyzed for the presence of formaldehyde using a colorimetric formaldehyde assay based on a carbazole reaction. 100 µl of THPC at different concentrations (ranging from 0 to 0.43 M) was mixed with 3 ml of concentrated sulfuric acid in borosilicate test tubes. Subsequently, 100 µl of 0.1% carbazole in ethanol was added, and the mixture was left to incubate at room temperature for 90 minutes. The absorbance was measured at 649 nm.
· To study the reaction between THPC and lysine, glycine, proline, and cysteine, the amino acids were combined in a 10:1 molar ratio with 0.43 M THPC, mixed, and allowed to incubate at room temperature for 20 minutes. The colorimetric assay was then conducted on the samples according to the same procedure.

Alfa Chemistry

For product inquiries, please use our online system or send an email to .

Alfa Chemistry
Inquiry Basket
qrcodex
Download
Verification code
* I hereby give my consent that I may receive marketing e-mails with information on existing and new services from this company. I know that I can opt-out from receiving such e-mails at any time or by using the link which will be provided in each marketing e-mail.